SCHOTT to Strengthen Pharmaceutical Site in Hungary
News Jun 10, 2013
SCHOTT Pharmaceutical Systems has announced plans to significantly expand its Hungarian site Lukácsháza that manufactures pharmaceutical primary packaging.
Investments in the mid-double-digit million euro range are planned from now until 2016.
The first step will be to open a new maintenance facility for overhauling and upgrading production machines that will create more than 30 new jobs in the Lukácsháza region.
In addition, production capacity should continue to increase in Hungary over the next few years.
SCHOTT manufactures ampoules, vials, and cartridges or so-called primary packaging for the pharmaceutical industry at its site in Lukácsháza near the Hungarian-Austrian border. The plant has continued to grow since it first opened in 1993.
Today, Lukácsháza, with its roughly 530 employees and annual production of more than 1.7 billion units, is the SCHOTT Pharmaceutical Division's single largest site.
The products manufactured in Lukácsháza are mainly exported to all parts of Europe and overseas, but also produced for the local market.
In addition to opening this global maintenance center, SCHOTT has also established a team of experts at this site that will overhaul its production machines on a regular basis and upgrade them to meet the latest technical standards.
“By doing so, we actively demonstrate our commitment to living up to the highest standards for quality and maintaining these over the long-term, in fact even for all of our global plants,” explains Dr. Jürgen Sackhoff, Vice President of SCHOTT Pharmaceutical Systems.
For Dr. Frank Heinricht, Chairman of the Board of Management, the expansion of the site in Hungary is only part of what can be considered a global investment strategy. After all, SCHOTT also intends to install new production lines in Hungary over time.
“On average, our annual production of ampoules, cartridges and vials will increase by almost half at this site,” Heinricht says and adds, “With our investment strategy, we will be helping our customers around the world to meet their quality and growth targets.”
The company also opened a new plant in India just recently and significantly expanded its capacities in Indonesia and Russia. A new joint venture in China also further expands its global manufacturing network.
Strong base in the region
SCHOTT’s expansion in Hungary also sends a powerful message to the Lukácsháza region. “We are aware of our importance as a local employer,” explains Christoph Döppes, Managing Director of the site in Lukácsháza.
“Our commitment here is long-term in nature and we are working together with the local authorities on further developing this site,” he adds.
Besides opening its new machine building facility, which received public funding support, and expanding its production capacities, SCHOTT also plans to create a number of new skilled jobs for machine builders, technicians and engineers, for instance.
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018